MBRS-12. INTERFERENCE WITH THE FUNCTION OF MYC IN GROUP 3 MEDULLOBLASTOMA

High-risk medulloblastoma (MB) is a deadly disease with poor overall survival. Survivors suffer from severe treatment-associated morbidity. Patients with Group 3 MB with an amplification of MYC show particularly poor outcome. Therefore novel therapies tailored to this subgroup are urgently needed. W...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Ecker, Jonas, Thatikonda, Venu, Oehme, Ina, Valinciute, Gintvile, Selt, Florian, Buhl, Juliane L, Usta, Diren, van Tilburg, Cornelis M, Herold-Mende, Christel, Schnölzer, Martina, Warnken, Uwe, Kool, Marcel, Jäger, Natalie, Pfister, Stefan M, Witt, Olaf, Milde, Till
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012712/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.457
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller